Usually, when investing for income, price appreciation comes as a secondary objective. Hence, such factors as below sector average valuations, too aggressive discount factor by the market, or embedded catalysts for significant upside move are not that crucial when deciding, where Roberts Berzins has over a decade of experience in the financial management helping top-tier corporates shape their financial strategies and execute large-scale financings. He has also made significant efforts to institutionalize R ...

Group 1 - The article emphasizes the importance of earnings reports in revealing insights about holdings and generating potential investment opportunities [1] - The author, Austin Rogers, specializes in REITs and focuses on high-quality dividend growth stocks aimed at creating a sustainable passive income stream [1] - The investment community, High Yield Landlord, offers exclusive research and resources for investors interested in the global REIT sector [1] Group 2 - The article does not provide specific financial data or performance metrics related to the companies mentioned [2]

iREIT+HOYA Capital is the premier income-focused investing service on Seeking Alpha. Our focus is on income-producing asset classes that offer the opportunity for sustainable portfolio income , diversification , and inflation hedging . Get started with a Free Two-Week Trial and take a look at our top ideas across our exclusive income-focused portfolios.What I like about the stock market is that it’s not rational, thereby creating opportunities for value investors. Overpriced stocks can remain that way for a ...

Financial Data and Key Metrics Changes - Total revenues and NOI for Q3 2024 increased by 10.9% and 12.5% respectively compared to Q3 2023, driven by solid same-property performance and execution of development strategies [25][26] - FFO per share diluted as adjusted for the quarter was $2.37, up 4.9% over Q3 2023, aligning with consensus expectations [25][26] - Collections remained high at 99.9%, with adjusted EBITDA margins at 70% for the quarter [26] Business Line Data and Key Metrics Changes - Leasing volume for the quarter was 1.5 million square feet, up 48% over the trailing four-quarter average, marking the highest quarterly volume since Q4 2022 [26] - GAAP and cash rental increases were 1.5% and 5.1% respectively, influenced by a significant non-laboratory lease renewal with a high-credit tech tenant [19][26] - Same-property NOI growth for Q3 2024 was solid at 1.5%, with cash basis growth at 6.5% [29] Market Data and Key Metrics Changes - The life science industry continues to show resilience, with venture capital deployment to private biotech tenants tracking to eclipse 2023, potentially marking the third highest year on record [11][12] - The IPO market has opened up, with over half of the companies that went public in 2024 trading above their issue price, indicating a positive trend for future leasing demand [13] - Commercial stage public biopharma and large multinational pharma continue to commit significant resources to R&D, with over $200 billion cash on hand among the top 25 biopharma companies [13] Company Strategy and Development Direction - The company aims to reinforce its core through a differentiated mega campus strategy, with 76% of annual rental revenue coming from these campuses [34][41] - The strategy includes disposing of non-core assets to enhance the quality of the asset base and focus on stabilized properties [35][41] - The company expects to generate $510 million of incremental net operating income from its development and redevelopment projects over the next 3.5 years [33] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the life science industry, highlighting its potential for innovation and growth despite a challenging economic backdrop [4][8] - The company anticipates some pressure on fourth quarter same-property results due to a lease termination, but overall expects solid growth for the full year [30] - Management remains committed to maintaining a strong balance sheet and disciplined funding strategy, with a targeted net debt to adjusted EBITDA leverage ratio of 5.1x by year-end [34] Other Important Information - The company closed on over $300 million of asset sale transactions in Q3 2024, including a significant sale to the Fred Hutchinson Cancer Research Center [21][22] - The company has $577.2 million of pending dispositions subject to non-refundable deposits, with expectations to close these transactions by year-end [36][38] - The average annual increase in dividends per share has been 5.4% since 2020, with a conservative FFO payout ratio of 55% for Q3 2024 [39] Q&A Session Summary Question: Insights on the Seattle asset sale and pending sales cap rates - Management clarified that the difference in cap rates between the Seattle asset sale (4.9%) and pending sales (7.5% cash cap rate) is due to the nature of the assets and their lease terms [42][47] Question: Dollar value of non-core assets and potential sales pipeline - Management indicated that while some non-core assets may be sold, there are valuable assets that may be retained, and land not located in mega campuses could also be a capital source [52][53] Question: Realized gains guidance for the full year - Management confirmed that realized gains for the quarter were $23 million, with year-to-date gains at $85.2 million, aligning with the guidance range of $95 million to $125 million [53] Question: Lease extension with a tech tenant in Texas - Management noted that the lease renewal was integral to the tenant's campus, and while the long-term plans are uncertain, the cash flow is preferable in the current market [55][56] Question: Larger space requirements and leasing demand - Management observed steady demand for revenue-generating spaces, but noted that medium-sized tenant demand remains challenging [57]

Alexandria Real Estate Equities, Inc. (ARE) reported third-quarter 2024 adjusted funds from operations (AFFO) per share of $2.37, missing the Zacks Consensus Estimate by a penny. However, the reported figure outpaced the year-ago quarter’s AFFO per share of $2.26 by 4.9%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Results reflected a rise in revenues, aided by decent leasing activity and rental rate growth. Alexandria narrowed its 2024 outlook.Total revenues of $791.6 million in ...

For the quarter ended September 2024, Alexandria Real Estate Equities (ARE) reported revenue of $791.61 million, up 10.9% over the same period last year. EPS came in at $2.37, compared to $0.13 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $775.93 million, representing a surprise of +2.02%. The company delivered an EPS surprise of -0.42%, with the consensus EPS estimate being $2.38.While investors closely watch year-over-year changes in headline numbers -- revenue ...

Alexandria Real Estate Equities (ARE) came out with quarterly funds from operations (FFO) of $2.37 per share, missing the Zacks Consensus Estimate of $2.38 per share. This compares to FFO of $2.26 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an FFO surprise of -0.42%. A quarter ago, it was expected that this life science real estate company would post FFO of $2.34 per share when it actually produced FFO of $2.36, delivering a surprise of 0.85%. O ...

| --- | --- | --- | --- | --- | |-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-------|------------------------------------ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to ____________ Commission file number 1-12993 ALEXANDRIA REAL ESTATE EQUITIES, INC. (Exact name of registrant as specified in its charter) M ...

Alexandria Real Estate Equities Inc. (ARE) is scheduled to release third-quarter 2024 results on Oct. 21 after the closing bell. Its quarterly results are likely to reflect growth in revenues and funds from operations (FFO) per share. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. In the last reported quarter, this Pasadena, CA-based life science real estate investment trust (REIT), focusing on collaborative life science, agtech and technology campuses in AAA innovation cluster lo ...